Entry |
|
Name |
Carmofur;
1-Hexylcarbamoyl-5-fluorouracil
|
Formula |
C11H16FN3O3
|
Exact mass |
257.1176
|
Mol weight |
257.26
|
Structure |

|
Remark |
|
Reaction |
|
Pathway |
map00983 | Drug metabolism - other enzymes |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC04 Carmofur
D01784 Carmofur (JP18/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
D01784 Carmofur
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
TYMS
D01784 Carmofur (JP18/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01784 Carmofur
Prodrugs [br08324.html]
D01784
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 18
1 N4x N 24.1102 -16.8225
2 C8y C 24.0859 -15.4359
3 C8y C 22.8254 -14.7238
4 C8x C 21.6261 -15.4580
5 N4y N 21.6504 -16.8445
6 C8y C 22.9110 -17.5568
7 O5x O 22.8655 -18.9433
8 X F 22.8009 -13.3373
9 O5x O 25.2852 -14.7017
10 C5a C 20.5112 -17.5420
11 N1b N 19.2875 -16.9277
12 O5a O 20.5021 -18.9885
13 C1b C 18.0656 -17.6356
14 C1b C 16.8477 -16.9325
15 C1b C 15.6300 -17.6356
16 C1b C 14.4122 -16.9325
17 C1b C 13.1943 -17.6356
18 C1a C 11.9765 -16.9325
BOND 18
1 2 9 2
2 3 4 2
3 5 10 1
4 4 5 1
5 10 11 1
6 5 6 1
7 10 12 2
8 6 1 1
9 6 7 2
10 1 2 1
11 3 8 1
12 2 3 1
13 11 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 17 18 1
|